FDA Approves First Generics of Heart Failure Combo Drug Entresto
Jun 3, 2024 · The Food and Drug Administration (FDA) has approved the first generics of Entresto ® (sacubitril and valsartan; Novartis) tablets.. The combination of sacubitril, a neprilysin inhibitor, and ...
The MPR Drug Reference Database for Healthcare Practitioners
View our rich drug database that contains concise drug information on more than 4,000 drugs and provides indication, dose, contraindications, precautions, interactions, adverse reactions ...
Hydrocodone/acetaminophen (325mg) - MPR
Hydrocodone bitartrate, acetaminophen; 5mg/325mg, 7.5mg/325mg, 10mg/325mg; scored tabs. Use lowest effective dose for shortest duration. Individualize. 5mg/325mg: 1–2 tabs every 4–6hrs as ...
FDA Drug Approval Decisions Expected in January 2025 - MPR
Dec 6, 2024 · The FDA is expected to decide on treatments for EBV-positive posttransplant lymphoproliferative disease, breast cancer, Barth syndrome, pain, and migraine.
High-Alert Medications - MPR
Oct 21, 2014 · High-Alert Medications according to ISMP guidelines
STROMECTOL Prescription & Dosage Information - MPR
STROMECTOL prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and STROMECTOLside effects.
Rybelsus (semaglutide) Dosage & Prescription Information - MPR
RYBELSUS prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and RYBELSUSside effects.
Prednisone Prescription & Dosage Information - MPR
Prednisone Tablets are indicated for the following conditions: Endocrine Disorders. Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic ...
Prescription & OTC Drug Info | Side Effects, Interactions & Dosages
MPR provides drug monographs, drug news and e-prescribing service for healthcare professionals. We provides drug dosing, interactions, recalls and more for medical professionals.
DO NOT CRUSH OR CHEW (Part 2 of 3) Generic Brand Generic Brand MODIFIED-RELEASE FORMULATION (continued) colestipol Colestid naproxen EC Naprosyn, Naprelan cyclobenzaprine Amrix nevirapine Viramune ...